S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial

被引：0

作者：

Shi, Yuankai ^{[1
,2
]}

Wang, Mengzhao ^{[3
]}

He, Jianxing ^{[4
]}

Chang, Jianhua ^{[5
]}

Han, Baohui ^{[6
]}

Liu, Xiaoqing ^{[7
]}

Chen, Gongyan ^{[8
]}

Zhou, Caicun ^{[9
]}

Liu, Jiwei ^{[10
]}

Pan, Hongming ^{[11
]}

Huang, Cheng ^{[12
]}

Zhang, Shucai ^{[13
]}

Feng, Jifeng ^{[14
]}

Lin, Xiaoyan ^{[15
]}

Wang, Jie ^{[16
]}

Huang, Jianjin ^{[17
]}

Li, Fang ^{[18
]}

Qin, Shukui ^{[19
]}

Wang, Zhehai ^{[20
]}

Wang, Liwei ^{[21
]}

Xu, Nong ^{[22
]}

机构：

[1] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China

[2] Peking Union Med Coll, Natl Ctr Anticanc Drugs Clin Study, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing 100021, Peoples R China

[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China

[4] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[5] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China

[6] Shanghai Chest Hosp, Shanghai, Peoples R China

[7] Acad Mil Med Sci, Affiliated Hosp, Beijing, Peoples R China

[8] Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China

[9] Shanghai Pulm Hosp, Shanghai, Peoples R China

[10] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China

[11] Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China

[12] Fujian Prov Tumor Hosp, Fuzhou, Peoples R China

[13] Beijing Chest Hosp, Beijing, Peoples R China

[14] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China

[15] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China

[16] Beijing Canc Hosp, Beijing, Peoples R China

[17] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China

[18] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China

[19] 81 Hosp PeopleS Liberat Army, Nanjing, Peoples R China

[20] Shandong Canc Hosp, Jinan, Peoples R China

[21] Shanghai First PeopleS Hosp, Shanghai, Peoples R China

[22] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

S-1; phase; 3; trial; Therapy; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL01.06

引用

页码：S174 / S174

页数：1

共 50 条

[21] Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)
Lee, Keun-Wook
Chung, Ik-Joo
Ryu, Min-Hee
Park, Young Iee
Nam, Byung-Ho
Oh, Ho-Suk
Lee, Kyung Hee
Han, Hye Sook
Seo, Bong-Gun
Jo, Jae-Cheol
Lee, Hyo Rak
Kim, Jin Won
Park, Sook Ryun
Cho, Sang Hee
Kang, Yoon-Koo
GASTRIC CANCER, 2021, 24 (01) : 156 - 167
[22] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
Hosokawa, Ayumu
Ando, Takayuki
Ogawa, Kohei
Ueda, Akira
Yoshita, Hiroki
Mihara, Hiroshi
Fujinami, Haruka
Kajiura, Shinya
Yabushita, Kazuhisa
Horikawa, Naoki
Kobayashi, Yuka
Yoshioka, Akira
Origasa, Hideki
Sugiyama, Toshiro
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
[23] RANDOMIZED PHASE III TRIAL OF S-1 PLUS CISPLATIN VERSUS DOCETAXEL PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG CANCER (TCOG0701)
Sakai, H.
Gemma, A.
Kubota, K.
Nishio, M.
Okamoto, H.
Inoue, A.
Isobe, H.
Kobayashi, K.
Takeuchi, M.
Kudoh, S.
ANNALS OF ONCOLOGY, 2012, 23 : 404 - 404
[24] Randomized phase III trial of S-1 plus cisplatin versus docetaxel plus cisplatin for advanced non-small-cell lung cancer (TCOG0701)
Katakami, Nobuyuki
Gemma, Akihiko
Sakai, Hiroshi
Kubota, Kaoru
Nishio, Makoto
Inoue, Akira
Okamoto, Hiroaki
Isobe, Hiroshi
Kunitoh, Hideo
Takiguchi, Yuichi
Kobayashi, Kunihiko
Nakamura, Yoichi
Ohmatsu, Hironobu
Sugawara, Shunichi
Minato, Koichi
Fukuda, Masaaki
Yokoyama, Akira
Takeuchi, Masahiro
Michimae, Hirofumi
Kudoh, Shoji
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[25] Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).
Lee, Choong-kun
Jung, Minkyu
Kang, Seok Yun
Kim, Bong-Seog
Kim, Ki Hyang
Lee, Kyung Hee
Lee, Moon Hee
Shin, Dong Bok
Zang, Dae Young
Ahn, Ji Yeong
Kim, Hyoung-il
Hyung, Woo Jin
Noh, Sung Hoon
Kim, Hyo Song
Chung, Hyun Cheol
Rha, Sun Young
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[26] RANDOMIZED PHASE III TRIAL OF S-1 PLUS CISPLATIN VERSUS DOCETAXEL PLUS CISPLATIN FOR ADVANCED NON SMALL-CELL LUNG CANCER (TCOG0701)
Tanaka, Hiroshi
Genma, Akihiko
Sakai, Hiroshi
Nishio, Makoto
Inoue, Akira
Okamoto, Iliroaki
Takiguchi, Yuichi
Isob, Hiroshi
Kunitoh, Hideo
Kubota, Kaoru
Nakamura, Yoichi
Kobayashi, Kunihiko
Takeuchi, Masahiro
Kudoh, Shoji
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S445 - S445
[27] A Randomized Phase II Trial of S-1 plus Cisplatin or Docetaxel plus Cisplatin with Concurrent Thoracic Radiotherapy for Stage III NSCLC: TORG1018
Yamada, Kazuhiko
Shimokawa, Tsuneo
Okamoto, Hiroaki
Tanaka, Hiroshi
Kubota, Kaoru
Kishi, Kazuma
Saito, Haruhiro
Takiguchi, Yuichi
Hosomi, Yukio
Kato, Terufumi
Harada, Daijiro
Masuda, Noriyuki
Kasai, Hisashi
Nakamura, Yoichi
Minato, Koichi
Kaburagi, Takayuki
Naoki, Katsuhiko
Hikino, Koji
Yamanaka, Takeharu
Watanabe, Koshiro
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S863 - S863
[28] S-1 combined with docetaxel (SD) versus S-1 combined with cisplatin (SP) in the treatment of advanced gastric cancer: randomized, controlled, multicenter and clinical study
Lu, Jianwei
Zhou, Zhaofei
Wu, Changping
Qian, Xiaoping
Chen, Xiaofei
Chen, Ping
Mao, Guoxin
Wang, Lin
Zheng, Yitong
Feng, Jifeng
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9359 - 9365
[29] Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus
Ojima, Toshiyasu
Nakamura, Masaki
Nakamori, Mikihito
Katsuda, Masahiro
Hayata, Keiji
Maruoka, Shimpei
Shimokawa, Toshio
Yamaue, Hiroki
ONCOLOGY, 2018, 95 (02) : 116 - 120
[30] A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer
Ajani, J. A.
Abramov, M.
Bondarenko, I.
Shparyk, Y.
Gorbunova, V.
Hontsa, A.
Otchenash, N.
Alsina, M.
Lazarev, S.
Feliu, J.
Elme, A.
Esko, V.
Abdalla, K.
Verma, U.
Benedetti, F.
Aoyama, T.
Mizuguchi, H.
Makris, L.
Rosati, G.
ANNALS OF ONCOLOGY, 2017, 28 (09) : 2142 - 2148

← 1 2 3 4 5 →